New York, NY -- (SBWIRE) -- 12/13/2013 -- StockMarketIntel.com issues a special report on the following stocks: RadioShack Corporation (NYSE:RSH), GeoVax Labs, Inc. (OTCMKTS:GOVX), E-House (China) Holdings Limited (ADR) (NYSE:EJ), Hemispherx BioPharma, Inc (NYSEMKT:HEB)
RadioShack Corporation (NYSE:RSH) declined -1.83%, trading on 2.35 million shares, to end the trade at $2.68. The stock changed hands in a range of $2.66 to $2.74, bringing its market capitalization to about $268.43 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $2.05 and was moved to the maximum level of $4.36. RadioShack Corporation engages in the retail sale of consumer electronics goods and services through its RadioShack store chain. The company operates in two segments, U.S. RadioShack company-operated stores and Target Mobile centers.
Will RSH Reach the Bottom after Yesterday’s Correction? Find Out Here
GeoVax Labs, Inc. (OTCMKTS:GOVX) declined -33.71%, to complete the trading session at $0.590, with a total volume of 1.02 million shares. The stock, on average, trades on a volume of 89,593 shares. It floated in a range of $0.47 to $0.80 during the last trading session, with a beta value of 1.65. Its market capitalization now moved to about $12.78 million. In the past 52 weeks, the share price has not declined below $0.35 and above $0.97. GeoVax Labs, Inc. operates as a biotechnology company. It focuses on developing vaccines that prevent and fight human immunodeficiency virus (HIV) infections that result in acquired immunodeficiency syndrome (AIDS).
Will GOVX Bounce Back After yesterday’s Sharp Sell off? Find Out Here
E-House (China) Holdings Limited (ADR) (NYSE:EJ) recorded a gain of 6.81% and was in a range of $12.88-$14.19 before closing at $13.80. The stock completed the day with a total volume of 4.89 million shares, versus an average volume of 3.25 million shares. The share price hit its 52-week low of $3.64 and $14.19 was the best price. E-House (China) Holdings Limited, through its subsidiaries, operates as a real estate services company in China. The company offers primary real estate agency services; real estate information services, such as data subscription and data integration services; and real estate consulting services comprising land acquisition and project consulting services.
What was the Moving Force behind EJ on Bullish Run? Read This Research Report
Hemispherx BioPharma, Inc (NYSEMKT:HEB) declined -5.03% yesterday, bringing its market capitalization around $44.60 million. The share price, after opening at $0.28, made a high of $0.28 and hovered above $0.25 to end the day at $0.266. The total number of shares that changed hands during the session was 2.18 million shares, as compared to average trading volume of 1.44 million shares. Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
Is it the Right to Grab HEB after the Recent Slump? Get Free Trend Analysis Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)